-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G7rXFm+EV9wYKrlFGKMc8Dpswwn9FwpfLXQzDlhblM73oFeOX3L4WiiDZjLBwUu9 uZVbhoQXkDX9M+9Yvs+ONA== 0001209191-05-005134.txt : 20050127 0001209191-05-005134.hdr.sgml : 20050127 20050127153604 ACCESSION NUMBER: 0001209191-05-005134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050126 FILED AS OF DATE: 20050127 DATE AS OF CHANGE: 20050127 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VIACELL INC CENTRAL INDEX KEY: 0001114529 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 043244816 BUSINESS ADDRESS: STREET 1: 131 CLARENDON ST CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6172664373 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pollard-Knight Denise CENTRAL INDEX KEY: 0001297000 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51110 FILM NUMBER: 05553736 BUSINESS ADDRESS: BUSINESS PHONE: 6179959800 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-01-26 0 0001114529 VIACELL INC VIAC 0001297000 Pollard-Knight Denise C/O NOMURA INTERNATIONAL PLC 1 ST. MARTIN'S LE GRAND LONDON X0 EC1A 4NP UNITED KINGDOM 1 0 0 0 Common Stock 2005-01-26 4 C 0 1692184 A 1692184 I See footnote Series H Convertible Preferred Stock 2005-01-26 4 C 0 1567184 D 2005-01-26 Common Stock 1567184 0 I See footnote Series I Convertible Preferred Stock 2005-01-26 4 C 0 125000 D 2005-01-26 Common Stock 125000 0 I See footnote Not applicable. The shares are owned by Nomura International plc. The reporting person is the Head of Nomura Phase4 Ventures. Nomura Phase4 Ventures Limited is managing the shares on behalf of Nomura International plc and is a subsidiary of Nomura International plc. The reporting person and Mr. Yoshiki Hashimoto (in his capacity as a director of Nomura Phase4 Ventures Limited and as Head of Merchant Banking, Nomura International plc) both together have voting and dispositive power of these shares. These shares automatically converted on a one-to-one basis into shares of common stock on the date of the closing of the initial public offering of the issuer's common stock. Marc A. Rubenstein Attorney-in-fact 2005-01-27 -----END PRIVACY-ENHANCED MESSAGE-----